News

Fortive Corporation Reports Impressive Annual and Q4 Results

Fortive Corporation Reports Impressive Annual and Q4 Results

Fortive Corporation Announces Strong Financial Results

Fortive Corporation (“Fortive”) (NYSE: FTV) has reported outstanding financial results for the fourth quarter and full year of 2024, highlighting its robust performance and resilience in the current market landscape.

Fourth Quarter Overview

In the fourth quarter, Fortive achieved net earnings of $209 million, while adjusted net earnings reached $406 million. The company reported diluted net earnings per share of $0.60, and adjusted diluted net earnings per share amounted to $1.17. Revenue climbed by 2% year-over-year, totaling $1.62 billion, with a core revenue growth of 2%.

Full Year Highlights

For the complete year, Fortive’s net earnings were $833 million, with adjusted net earnings at $1.37 billion. The diluted net earnings per share stood at $2.36, and adjusted diluted earnings per share were $3.89. Full-year revenues reached $6.23 billion, showing a 3% growth over the previous year, encouraged by a 1% growth in core revenue.

Comments from Leadership

James A. Lico, President and CEO, commented on the results, stating, “Our fourth quarter results once again demonstrated strong execution despite the challenging macro environment. We saw continued growth across our Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS) segments, fueled by steady demand for safety and productivity solutions.”

Outlook for 2025

Looking ahead, Fortive aims for revenues between $1.48 billion to $1.51 billion in the first quarter of 2025. For the entire year, expected revenues are anticipated to be approximately $6.23 billion to $6.35 billion, with diluted net earnings per share forecasted between $2.38 to $2.50, alongside adjusted figures ranging from $4.00 to $4.12. The guidance provided does not reflect the anticipated separation of its Precision Technologies segment.

Strategic Separation Update

On September 4, 2024, Fortive announced its plans to separate its Precision Technologies business into an independent company named Ralliant. This strategic move aims to establish two operationally distinct entities, each focused on specific market segments. The process is expected to be a tax-free spin-off for Fortive shareholders, pending conditions such as final board approvals and regulatory review.

Conference Call Insights

Fortive held an investor conference call to discuss these results and their outlook. Investors can review detailed presentations made during the call on Fortive’s official website. A recording of the conference call will subsequently be available for those who were unable to attend.

About Fortive Corporation

Fortive is dedicated to providing essential technologies that facilitate connected workflow solutions across various attractive end-markets and engaging in continuous improvement through the application of the Fortive Business System. The company’s portfolio consists of well-regarded brands within its strategic sectors, which include Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions, all committed to driving significant market impacts.

Frequently Asked Questions

What are the key financial results for Fortive in Q4 2024?

Fortive reported net earnings of $209 million for Q4 2024, with adjusted earnings of $406 million and revenues reaching $1.62 billion.

What is Fortive’s forecast for Q1 2025?

Fortive expects revenues between $1.48 billion to $1.51 billion in Q1 2025, with diluted net earnings per share projected at $0.39 to $0.42.

How has Fortive's revenue growth been in 2024?

For the full year 2024, Fortive's total revenues increased by 3% year-over-year, reaching $6.23 billion.

What strategic changes are in store for Fortive?

Fortive plans to separate its Precision Technologies segment into a new independent entity, Ralliant, targeting completion in early 2025.

Where can I find more information about Fortive’s financial performance?

More details can be found on Fortive's official website, where recordings of conference calls and official presentations are made available.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Rain Agent Vaults: Revolutionizing Payments with AI

Updated Category News Views 123

Innovative Payments with AI Power Alright, folks, Rain's gone and done something that's probably going to shake things up in the payments world—'cause they've given AI agents the ability to handle money like never before. We're not just talking about some run-of-the-mill integration here. This is a genuine game changer, promising to make agents as financially savvy as...

Continue Reading
ProBio, AbTis Forge Bond for Next-Gen Oncology ADCs

Updated Category News Views 99

Deal or No Deal: ProBio's New Licensing Agreement In the ever-evolving realm of biopharmaceuticals, ProBio's recent handshake with South Korea's AbTis is stirring the pot. The shot-callers at ProBio are passing the baton to AbTis, giving them a crack at developing a thumping new therapeutic antibody asset aimed squarely at oncology targets. Pretty slick move if you ask...

Continue Reading
Alogent's Unify Snags Award for Innovation and Impact

Updated Category News Views 104

Innovation That Captures Attention Alogent sure did grab the spotlight with their Unify platform walking away with a Credit Union Times Luminaries Award. The name of the game here is deposit processing innovation—the kind of buzz that turns heads in the banking world. This recognition isn't just another plaque for the lobby; it's a testament to a significant stamp on...

Continue Reading
Sokolove Law Wins $28.8M Verdict for Misdiagnosis Case

Updated Category News Views 122

Jury Awards $28.8 Million in Misdiagnosis Case Well, here's a tale that's bound to ruffle some feathers in the medical community—$28.8 million tossed on the table because an emergency room missed a life-threatening aortic aneurysm. For the uninitiated, this isn't just chump change; it's the cost of dropping the ball when the stakes are as high as a human life. A jury in...

Continue Reading
FirstDigital Expands Fiber Network in Utah and Arizona

Updated Category News Views 86

Weaving a Web of Connectivity Let's talk about FirstDigital putting its shoulder to the wheel in Utah and Arizona. They're expanding their redundant fiber network to rope in more businesses under their umbrella of connectivity. This ain't just another dry IT endeavor—it's about building a safety net for our ever-connected world. The Stakes of Network Disruption You know...

Continue Reading
Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Updated Category News Views 73

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Continue Reading
Alyssa Bunch: Big Moves in Tennessee Real Estate

Updated Category News Views 104

Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...

Continue Reading
Bakersfield Sees Spike in Crashes Post Time Change

Updated Category News Views 83

Evening Darkness and Safety Concerns Folks, it seems Bakersfield streets transform into a battlefield once the clock falls back. With darkness creeping in earlier, those evening hours right after the time change see a sobering uptick in accidents. According to an analysis by Chain | Cohn | Clark, pedestrian and bicyclist crashes from 5 to 7 p.m. double. It's not just...

Continue Reading
IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

Updated Category News Views 5

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Continue Reading
Zephyr's Alto Hood: Redefining Kitchen Versatility

Updated Category News Views 75

An Artist in the Kitchen Who knew a kitchen hood could be a canvas, right? Zephyr, always a punch above the ordinary in kitchen design, has pulled another rabbit out of their hat with the Alto Wall Custom Hood. Forget blending in; this piece is about standing out and shouting style—all while keeping your cooking area fresh. Options Galore The Alto Hood isn't about...

Continue Reading

Top 5 Most Recently Viewed Articles

Constellation Brands Schedules Earnings Call for Q2 2026

Updated Category News Views 395

Constellation Brands Sets New Reporting Date Constellation Brands, Inc. (NYSE: STZ), a prominent player in the beverage alcohol sector, has recently revised its reporting schedule for the financial results of its second quarter, which ended on August 31, 2025. The new reporting date is set for October 6, 2025, after the markets close. Investors and analysts will be able...

Continue Reading
Bullish Trends Continue for Charter Communications in Options Market

Updated Category News Views 212

Analyzing the Recent Options Trends of Charter Communications The options market is bustling with activity around Charter Communications, indicating a strong bullish sentiment. Investors with significant capital are positioning themselves favorably, potentially anticipating upward price movements for the stock, CHTR. Summary of Options Trading Activity Examining the...

Continue Reading
California Water Service Group's Insights on Sustainability Efforts

Updated Category News Views 386

California Water Service Group Advances Sustainability Initiatives In its latest report, California Water Service Group (NYSE: CWT) has unveiled significant progress on various sustainability efforts aimed at minimizing its environmental footprint and enhancing corporate responsibility. This comprehensive overview showcases the Group's dedication to maintaining high...

Continue Reading
Deadline Approaches for Outset Medical Class Action Investors

Updated Category News Views 50

Important Deadline for Outset Medical Investors Investors, it’s time to stay alert! There’s an upcoming deadline that you need to be aware of regarding the class action lawsuit against Outset Medical, Inc. This lawsuit concerns investors who purchased or acquired securities of Outset Medical during a specific period. With the deadline looming, many individuals may be...

Continue Reading
Investors Losing from ASML Holding N.V. Should Seek Justice

Updated Category News Views 145

Investors' Alert: Class Action Against ASML Holding N.V. ASML Holding N.V. (NASDAQ: ASML) is currently facing a class action securities lawsuit that aims to defend the interests of its investors who may have suffered financial losses. This legal move is significant, especially for those who have been adversely affected by certain events within the semiconductor industry....

Continue Reading